Literature DB >> 31656822

Inflammatory proteins in diabetic kidney disease-potential as biomarkers and therapeutic targets.

Angie S Xiang1, Elif I Ekinci2,3, Richard J MacIsaac3,4.   

Abstract

Entities:  

Year:  2019        PMID： 31656822      PMCID： PMC6789318          DOI： 10.21037/atm.2019.08.20

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  25 in total

1.  Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

Authors:  Tomohito Gohda; Monika A Niewczas; Linda H Ficociello; William H Walker; Jan Skupien; Florencia Rosetti; Xavier Cullere; Amanda C Johnson; Gordon Crabtree; Adam M Smiles; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

Review 2.  TNF receptors: signaling pathways and contribution to renal dysfunction.

Authors:  Rafia S Al-Lamki; Tanya N Mayadas
Journal:  Kidney Int       Date:  2014-08-20       Impact factor: 10.612

3.  High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.

Authors:  Elizabeth L M Barr; Federica Barzi; Jaquelyne T Hughes; George Jerums; Wendy E Hoy; Kerin O'Dea; Graham R D Jones; Paul D Lawton; Alex D H Brown; Mark Thomas; Elif I Ekinci; Ashim Sinha; Alan Cass; Richard J MacIsaac; Louise J Maple-Brown
Journal:  Diabetes Care       Date:  2018-01-24       Impact factor: 19.112

4.  Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes.

Authors:  Andreas Heinzel; Michael Kammer; Gert Mayer; Roman Reindl-Schwaighofer; Karin Hu; Paul Perco; Susanne Eder; Laszlo Rosivall; Patrick B Mark; Wenjun Ju; Matthias Kretzler; Peter Gilmour; Jonathan M Wilson; Kevin L Duffin; Moustafa Abdalla; Mark I McCarthy; Georg Heinze; Hiddo L Heerspink; Andrzej Wiecek; Maria F Gomez; Rainer Oberbauer
Journal:  Diabetes Care       Date:  2018-07-06       Impact factor: 19.112

Review 5.  'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'.

Authors:  Richard J MacIsaac; Elif I Ekinci; G Jerums
Journal:  Kidney Int       Date:  2014-04-09       Impact factor: 10.612

Review 6.  Microalbuminuria as a risk predictor in diabetes: the continuing saga.

Authors:  George L Bakris; Mark Molitch
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

7.  Urinary proteomics in diabetes and CKD.

Authors:  Kasper Rossing; Harald Mischak; Mohammed Dakna; Petra Zürbig; Jan Novak; Bruce A Julian; David M Good; Joshua J Coon; Lise Tarnow; Peter Rossing
Journal:  J Am Soc Nephrol       Date:  2008-04-30       Impact factor: 10.121

Review 8.  Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease.

Authors:  Lauren Winter; Lydia A Wong; George Jerums; Jas-Mine Seah; Michele Clarke; Sih Min Tan; Melinda T Coughlan; Richard J MacIsaac; Elif I Ekinci
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-22       Impact factor: 5.555

9.  Biomarker panels associated with progression of renal disease in type 1 diabetes.

Authors:  Marco Colombo; Erkka Valo; Stuart J McGurnaghan; Niina Sandholm; Luke A K Blackbourn; R Neil Dalton; David Dunger; Per-Henrik Groop; Paul M McKeigue; Carol Forsblom; Helen M Colhoun
Journal:  Diabetologia       Date:  2019-06-20       Impact factor: 10.122

10.  Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321
View more
  2 in total

Review 1.  Current updates on protein as biomarkers for diabetic kidney disease: a systematic review.

Authors:  Rani Sauriasari; Dhonna Dwi Safitri; Nuriza Ulul Azmi
Journal:  Ther Adv Endocrinol Metab       Date:  2021-10-27       Impact factor: 3.565

2.  Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes.

Authors:  Annayya R Aroor; Adam Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.